New composite endpoints to assess efficacy in periodontal therapy clinical trials.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  The Journal of Periodontology

• Publication date

  2006-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1902/JOP.2006.050275PMID 16881800
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial.

  2005cited by this paper
• Validity of composite end points in clinical trials

  2005cited by this paper
• Endpoints in periodontal trials: the need for an evidence-based research approach.

  2004cited by this paper
• OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.

  2004cited by this paper
• Composite outcomes in randomized trials: greater precision but with greater uncertainty?

  2003cited by this paper
• Periodontal regeneration in human Class II furcations using purified recombinant human platelet-derived growth factor-BB (rhPDGF-BB) with bone allograft.

  2003cited by this paper
• Periodontal regeneration in humans using recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and allogenic bone.

  2003cited by this paper
• Growth and amelogenin-like factors in periodontal wound healing. A systematic review.

  2003cited by this paper
• The efficacy of bone replacement grafts in the treatment of periodontal osseous defects. A systematic review.

  2003cited by this paper
• The Multiple Sclerosis Functional Composite: a new clinical outcome measure for multiple sclerosis trials

  2002cited by this paper
• Clinical evaluation of anorganic bovine bone xenograft with a bioabsorbable collagen barrier in the treatment of molar furcation defects.

  2001cited by this paper
• The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

  2001cited by this paper
• The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

  2001cited by this paper
• A retrospective radiographic outcome assessment study of intra-bony defects treated by osseous surgery or by bone graft procedures.

  2000cited by this paper
• Human histologic evaluation of a bovine-derived bone xenograft in the treatment of periodontal osseous defects.

  2000cited by this paper
• A controlled re-entry study on the effectiveness of bovine porous bone mineral used in combination with a collagen membrane of porcine origin in the treatment of intrabony defects in humans.

  2000cited by this paper
• Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.

  1999cited by this paper
• The accuracy of radiographic methods in assessing the outcome of periodontal regenerative therapy.

  1999cited by this paper
• Clinical, radiographic, and histologic evaluation of human periodontal defects treated with Bio-Oss and Bio-Gide.

  1998cited by this paper
• Comparison of 2 regenerative procedures--guided tissue regeneration and demineralized freeze-dried bone allograft--in the treatment of intrabony defects: a clinical and radiographic study.

  1998cited by this paper
• Design principles and statistical considerations in periodontal clinical trials.

  1997cited by this paper
• The use of biologic response modifiers in human clinical trials.

  1997cited by this paper
• A survey of endpoint characteristics in periodontal clinical trials published 1988-1992, and implications for future studies.

  1995cited by this paper
• Clinical use of a bioresorbable matrix barrier in guided tissue regeneration therapy. Case series.

  1994cited by this paper
• Clinical, microbiological, and histological factors which influence the success of regenerative periodontal therapy.

  1994cited by this paper
• Synthetic bioabsorbable barrier for regeneration in human periodontal defects.

  1994cited by this paper
• Evaluation of an absorbable collagen membrane in treating Class II furcation defects.

  1994cited by this paper
• Clinical evaluation of guided tissue regeneration in the treatment of grade II molar furcation invasions.

  1994cited by this paper
• Periodontal regeneration of human infrabony defects. III. Diagnostic strategies to detect bone gain.

  1993cited by this paper
• Automated periodontal probing and recording.

  1993cited by this paper
• Automated periodontal probing and recording.

  1993cited by this paper
• Measurement of attachment level in clinical trials: probing methods.

  1992cited by this paper
• Measurement of Attachment Level in Clinical Trials: Probing Methods.

  1992cited by this paper
• Radiographic methods in the evaluation of periodontal therapy.

  1992cited by this paper
• Radiographic Methods in the Evaluation of Periodontal Therapy.

  1992cited by this paper
• A comparison of probing and radiographic methods for detection of periodontal disease progression.

  1991cited by this paper
• A comparison of probing and radiographic methods for detection of periodontal disease progression.

  1991cited by this paper
• Evaluation of guided tissue regeneration in Class II furcation defects. A clinical re-entry study.

  1989cited by this paper
• Guided tissue regeneration in degree II furcation-involved mandibular molars. A clinical study.

  1988cited by this paper
• Repair of periodontal furcation defects in beagle dogs following reconstructive surgery including root surface demineralization with tetracycline hydrochloride and topical fibronectin application.

  1988cited by this paper
• Histologic and clinical responses to porous hydroxylapatite implants in human periodontal defects. Three to twelve months postimplantation.

  1987cited by this paper
• Human intraosseous healing responses to the placement of tricalcium phosphate ceramic implants. II. 13 to 18 months.

  1987cited by this paper
• An evaluation of tricalcium phosphate implants in human periodontal osseous defects of two patients.

  1985cited by this paper
• Alloplastic implants of tricalcium phosphate ceramic in human periodontal osseous defects.

  1984cited by this paper
• Healing responses of human intraosseous lesions following the use of debridement, grafting and citric acid root treatment. I. Clinical and histologic observations six months postsurgery.

  1983cited by this paper
• Fibrin linkage: a precursor for new attachment.

  1983cited by this paper
• Cementogenesis and soft tissue attachment after citric acid treatment in a human. An electron microscopic study.

  1983cited by this paper
• Healing responses of human intraosseous lesions following the use of debridement, grafting and citric acid root treatment. II. Clinical and histologic observations: one year postsurgery.

  1983cited by this paper
• Connective tissue attachment to periodontally diseased roots after citric acid demineralization.

  1982cited by this paper
• Effect of root surface alterations on periodontal healing. II. Citric acid treatment of the denuded root.

  1982cited by this paper
• Connective tissue regeneration to periodontally diseased teeth. A histological study.

  1980cited by this paper
• Comparison of tricalcium phosphate and frozen allogenic bone implants in man.

  1979cited by this paper
• The induction of new bone and cementum formation. IV. Microscopic examination of the periodontium following human bone and marrow allograft, autograft and nongraft periodontal regenerative procedures.

  1978cited by this paper
• Preliminary clinical studies of bioceramic in periodontal osseous defects.

  1978cited by this paper
• A Clinical and Histological Evaluation of Autogenous Iliac Bone Grafts in Humans: Part I. Wound Healing 2 to 8 Months

  1973cited by this paper
• A clinical and histological evaluation of autogenous iliac bone grafts in humans. I. Wound healing 2 to 8 months.

  1973cited by this paper

• Long term clinical results of intrabony defects treated with periodontal regeneration. A retrospective analysis based on composite outcome measure

  2025cites this paper
• Registration in the international prospective register of systematic reviews (PROSPERO) of systematic review protocols was associated with increased review quality.

  2018cites this paper
• A Randomized Clinical Trial Evaluating rh-FGF-2/β-TCP in Periodontal Defects

  2016cites this paper
• Growth factors and beta-tricalcium phosphate in the treatment of periodontal intraosseous defects: A systematic review and meta-analysis of randomised controlled trials.

  2016cites this paper
• A novel test to compare two treatments based on endpoints involving both nonfatal and fatal events

  2015cites this paper
• Periodontal Research: Basics and beyond – Part II (Ethical issues, sampling, outcome measures and bias)

  2013cites this paper
• Bone regeneration of tibial defects in rats with enzymatic hydrogelation of gelatin derivative and recombinant human platelet-derived growth factor-BB complex.

  2013cites this paper
• Platelet-derived growth factor promotes periodontal regeneration in localized osseous defects: 36-month extension results from a randomized, controlled, double-masked clinical trial.

  2013cites this paper
• Bias in Periodontal Research

  2012cites this paper
• Periodontal disease in association with systemic levels of interleukin-18 and CXC ligand 16 in patients undergoing cardiac catheterization.

  2010cites this paper
• Endpoints used for Relative Effectiveness Assessment Composite endpoints

  year unknowncites this paper